Considerations for Cross-Border Strategic Licenses and Collaborations for Asia-Based Life Sciences Companies

Join us for an overview of considerations and issues relevant to Asia-based companies entering cross-border strategic licenses and collaborations in the life sciences industry, including governing law, tax, intellectual property, data privacy, Committee on Foreign Investment in the United States/cross border, transactional flexibility, and differing approaches to contracting and collaborating.